Alaunos TherapeuticsTCRT
13F holders, Q2 2024 (June 30)3holders
$0.68avg. 13F price*
At the end of Q2 2024, 3 institutions reported holding Alaunos Therapeutics Inc. (TCRT) in their 13F filings. The largest holders were Harbor Investment Advisory, LLC ($17), Family Firm, Inc. ($5) and Ashton Thomas Private Wealth, LLC ($3).
- Company
- Alaunos Therapeutics Inc.
- CUSIP
- 98973P309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $25 |
| Exits | 0 | $0 |
Ownership 3 holders
| Harbor Investment Advisory, LLC | 0.00% | New | 25 | $17 |
| Family Firm, Inc. | 0.00% | New | 7 | $5 |
| Ashton Thomas Private Wealth, LLC | 0.00% | New | 5 | $3 |
"% of holder's portfolio" is TCRT's weight in each manager's 13F, not the share of Alaunos Therapeutics Inc. the manager owns.